ROC Compliance India (2026) : What Happens if you Filed it and What Happens if you Miss it

It should be noted that many private limited companies fail to comply with ROC obligations not because they choose to ignore them, but due to their complexity and unclear deadlines and filings. For example, a single missed submission of the AOC-4 or MGT-7 form may result in daily fines of ₹100 and, in the worst-case scenario, disqualification of the company's directors or even strike-off.
In actuality, ROC compliance encompasses much more than the submission of specific forms. Companies must prepare financial statements, file annual returns, update their directors' KYC, and provide information about any important events occurring within the organization during the year. Even inactive companies must perform such filings to maintain their legal existence.
As for the 2026 compliance cycle, it consists of three stages: AGM until the end of September, AOC-4 filing within 30 days, and MGT-7 submission within 60 days after the first step. The omission of this sequence leads to an entire chain of delays and further complications.

###

Sponsor Message

Many Americans turn to Canadian pharmacies for cost-effective access to life-saving drugs like Lipitor and Crestor for cholesterol, or Nexium for GERD relief. For diabetes management, Humalog and Lantus are commonly used, while asthma and COPD are treated with Advair Diskus and Ventolin inhalers. Medications like Zoloft, Prozac, and Abilify help address mental health needs, while Eliquis, Plavix, and Xarelto reduce the risk of heart-related events. Frequently ordered medications include popular pain and inflammation treatments like Celebrex and thyroid replacement therapy such as Synthroid. Additionally, erectile dysfunction can be treated with medications like Viagra and Cialis, and Type 2 diabetes is managed with Januvia. Managing severe sleepiness or narcolepsy is possible with wakefulness agents like Provigil and Nuvigil. Canadian pharmacies offer vital medications like Cymbalta for nerve pain and Aricept for Alzheimer's, ensuring affordable access for U.S. patients.